SCHEMBL16628732

SCHEMBL16628732

Cc1cccc(CN(C)C(=O)c2nc(N)nc3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.52
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
HSP90AA1 P07900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081057 0.89 CYP3A4 (0.53) ADORA3CYP2D6MEN1KMT2ACYP3A4
SCHEMBL3090418 0.88 SCD5 (0.52) APPCYP2D6MEN1KMT2AHPGD
SCHEMBL16628712 0.87 ADORA3 (0.56) APPADORA3
SCHEMBL16628770 0.86 HPGD (0.55) APPADORA3CYP2D6MEN1KMT2A
SCHEMBL16628737 0.85 TACR1 (0.54) APP
SCHEMBL13144374 0.83 AOC3 (0.46) CYP2D6MEN1KMT2ACYP3A4HSP90AA1
SCHEMBL16628767 0.83 CYP3A4 (0.48) ADORA3CYP2D6MEN1KMT2ALMNA
SCHEMBL16628717 0.82 LMNA (0.50) CYP2D6MEN1KMT2ALMNACYP1A2
SCHEMBL3087920 0.81 ADORA3 (0.52) APPADORA3MEN1KMT2ACYP1A2
SCHEMBL3087952 0.81 APP (0.48) APPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed